Literature DB >> 922702

Feasibility of fecal occult-blood testing for detection of colorectal neoplasia: debits and credits.

S J Winawer, D G Miller, D Schottenfeld, S D Leidner, P Sherlock, B Befler, M W Stearns.   

Abstract

A screening program for colorectal cancer and adenomas has been applied to 6,579 mostly asymptomatic men and women age 40 years and older utilizing fecal occult-blood testing followed by investigation of patients with positive slides by air-contrast barium enema and colonoscopy. A control population of 7,325 patients had sigmoidoscopy only and no occult-blood testing. Approximately 1% of the patients had positive slides; most patients had only one or two slides positive. Approximately 50% of patients with positive slides had significant neoplastic lesions, including 23 patients with large adenomas and 7 patients with cancers. Pathological staging of cancers was more favorable in the screened asymptomatic group as compared with the control group. Neoplastic lesions seen on sigmoidoscopy in screened patients who had negative fecal occult-blood tests included 2 cancers and 15 large adenomas. Reasons for false negativity include possible conversion of initially positive slides to negative. Screening for colorectal cancer and adenomas with fecal occult-blood testing appears to be feasible approach with good patient compliance, and manageable rate of positive slides productive of a high percentage of neoplastic lesions. The number of false-positives seems to be low. False negativity has been observed and will require further study.

Entities:  

Mesh:

Year:  1977        PMID: 922702     DOI: 10.1002/1097-0142(197711)40:5+<2616::aid-cncr2820400934>3.0.co;2-z

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  12 in total

Review 1.  A perspective on clinical research strategies in carcinoma of the large bowel.

Authors:  P H Sugarbaker
Journal:  World J Surg       Date:  1991 Sep-Oct       Impact factor: 3.352

2.  Problems and prevention in proctology.

Authors:  P R Knight
Journal:  Can Fam Physician       Date:  1982-06       Impact factor: 3.275

3.  Decrease in Incidence of Colorectal Cancer Among Individuals 50 Years or Older After Recommendations for Population-based Screening.

Authors:  Caitlin C Murphy; Robert S Sandler; Hanna K Sanoff; Y Claire Yang; Jennifer L Lund; John A Baron
Journal:  Clin Gastroenterol Hepatol       Date:  2016-09-05       Impact factor: 11.382

4.  Comparative studies on the "in vivo"-sensitivity of four commercial pseudoperoxidase-based faecal occult blood tests in relation to actual blood losses as calculated from measured whole body-59Fe-elimination rates.

Authors:  H C Heinrich; F Icagić
Journal:  Klin Wochenschr       Date:  1980-12-01

5.  Hemoccult II Screening for Bowel Cancer: Will Family Practice Patients Accept It?

Authors:  J F Sangster; T M Gerace; M J Bass
Journal:  Can Fam Physician       Date:  1986-02       Impact factor: 3.275

Review 6.  Colorectal Cancer in the Young: Does Screening Make Sense?

Authors:  Caitlin C Murphy
Journal:  Curr Gastroenterol Rep       Date:  2019-05-16

7.  Comparison of flexible sigmoidoscopy with other diagnostic techniques in the diagnosis of rectocolon neoplasia.

Authors:  S J Winawer; S D Leidner; C Boyle; R C Kurtz
Journal:  Dig Dis Sci       Date:  1979-04       Impact factor: 3.199

8.  Development of impression method of the colon using sodium alginate--experimental evaluation by the use of intestinal phantom.

Authors:  S Yoshimoto; S Otsuki; M Beppu; R Ohnishi; S Doi; K Kawai
Journal:  Gastroenterol Jpn       Date:  1980

9.  Colorectal cancer screening.

Authors:  W B Applegate; M H Spector
Journal:  J Community Health       Date:  1981

Review 10.  Screening for colorectal cancer: a critical review.

Authors:  J D Hardcastle; G Pye
Journal:  World J Surg       Date:  1989 Jan-Feb       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.